Autolus Therapeutics (AUTL) Capital Expenditures Growth (3y) (2021 - 2025)
Autolus Therapeutics (AUTL) Capital Expenditures Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.73 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.60 Bn | 467.81 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 122.34 Bn | 115.09 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 70.14 Bn | 61.39 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.79 Bn | 62.79 Bn | - | - |
| 8 | Argenx Se | 56.19 Bn | 51.00 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | 16.27% |
| 10 | Autolus Therapeutics | 396.55 Mn | 95.84 Mn | -1.04 Mn | -50.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -50.34% |
| Sep 30, 2025 | -5.92% |
| Jun 30, 2025 | 20.65% |
| Mar 31, 2025 | 120.30% |
| Dec 31, 2024 | 91.39% |
| Sep 30, 2024 | 35.42% |
| Jun 30, 2024 | -18.47% |
| Mar 31, 2024 | -33.65% |
| Dec 31, 2023 | -35.37% |
| Sep 30, 2023 | -28.21% |
| Jun 30, 2023 | 100.48% |
| Mar 31, 2023 | -7.23% |
| Jun 30, 2022 | -31.64% |
| Mar 31, 2022 | -52.79% |
| Jun 30, 2021 | -11.77% |